Sumatriptan needle-free subcutaneous (Sumavel^® DosePro™) approved for the acute treatment of migraine, with or without aura, and cluster headaches

References

• Ferrari MD, Roon KI, Lipton RB, Goadsby PJ. Oral triptans (serotonin 5-HT1B/1D agonists) in acute migraine treatment: a meta-analysis of 53 trials. Lancet358, 1668–1675 (2001).
   PubMed Web of Science ®Google Scholar
• Humphrey PPA, Feniuk W, Perren MJ, Connor HE, Oxford AW, Coats IH. GR43175, a selective agonist for the 5-HT-1-like receptor in dog saphenous vein. Br. J. Clin. Pharmacol.94, 1123–1132 (1988).
   Google Scholar
• Moskowitz MA, Buzzi MG. Evidence for 5-HT1B/1D receptor medicating the antimigraine effect of sumatriptan and dihydroergotamine. Cephalalgia11, 165–168 (1991).
   PubMedGoogle Scholar
• Moskowitz MA. Neurogenic inflammation in the pathophysiology and treatment of migraine. Neurology43(Suppl. 3), S16–S20 (1993).
   PubMed Web of Science ®Google Scholar
• Burstein R, Jakubowski M, Levy D. Anti-migraine action of triptans is preceded by transient aggravation of headache caused by activation of meningeal nociceptors. Pain115, 21–28 (2005).
   PubMed Web of Science ®Google Scholar
• MacIntyre PD, Bhargava B, Hogg KJ, Gemmill JD, Hillis WS. Effect of subcutaneous sumatriptan, a selective 5HT-1 agonist on the systemic, pulmonary, and coronary circulation. Circulation87, 401–405 (1993).
   PubMed Web of Science ®Google Scholar
• Scott AK, Walley T, Breckenridge AM, Lacey LF, Fowler PA. Lack of interaction between propanolol and sumatriptan. Br. J. Clin. Pharmacol.32, 581–584 (1991).
   PubMed Web of Science ®Google Scholar
• Van Heckn AM, Depre M, De Schepper PJ, Fowler PA, Lacey JM, Durham JM. Lack of effect of flunarizine on the pharmacokinetics and pharmacodynamics of sumatriptan in healthy volunteers. Br. J. Clin. Pharmacol.34, 82–84 (1992).
   PubMedGoogle Scholar
• Scott AK. Sumatriptan clinical pharmacokinetics. Clin. Pharmacokinet.27, 337–344 (1994).
   PubMed Web of Science ®Google Scholar
• Blier P, Bergeron R. The safety of concomitant use of sumatriptan and antidepressant treatments. J. Clin. Psychopharmacol.15, 106–109 (1995).
   PubMed Web of Science ®Google Scholar
• Leung M. Lack of an interaction between sumatriptan and selective serotonin reuptake inhibitors Headache35, 488–489 (1995).
   PubMed Web of Science ®Google Scholar
• Cady RK, Wendt JK, Kirchner JR, Sargent JD, Rothrock JF, Skaggs H Jr. Treatment of acute migraine with subcutaneous sumatriptan. JAMA265, 2831–2835 (1991).
   PubMed Web of Science ®Google Scholar
• The Subcutaneous Sumatriptan International Study Group. Subcutaneous sumatriptan in the acute treatment of migraine. N. Engl. J. Med.325, 316–321 (1991).
   PubMed Web of Science ®Google Scholar
• The Sumatriptan Cluster Headache Study Group. Treatment of acute cluster headache with sumatriptan. N. Engl. J. Med.325, 322–326 (1991).
   PubMed Web of Science ®Google Scholar
• Ekbom K, Monstad I, Prusinski A, Cole JA, Pilgrim AJ, Noronha D. Subcutaneous sumatriptan in the acute treatment of cluster headache: a dose comparison study. The Sumatriptan Cluster Headache Study Group. Acta Neurol. Scand.88, 63–69 (1993).
   PubMed Web of Science ®Google Scholar
• Burstein R, Collins B, Jakubowski M. Defeating migraine pain with triptans: a race against the development of cutaneous allodynia. Ann. Neurol.55, 19–26 (2004).
   PubMed Web of Science ®Google Scholar
• Burstein R, Jakubowski M. Analgesic triptan action in an animal model of intracranial pain: a race against the development of central sensitization. Ann. Neurol.55, 27–36 (2004).
   PubMed Web of Science ®Google Scholar
• Diamond S, Freitag FG, Feoktistov A, Nissan GR. Sumatriptan 6 mg subcutaneous as an effective migraine treatment in patients with cutaneous allodynia who historically fail to respond to oral triptans. J. Headache Pain8, 13–18 (2007).
   PubMedGoogle Scholar
• Linde M, Mellberg A, Dahlof C. Subcutaneous sumatriptan provides symptomatic relief at any pain intensity or time during the migraine attack. Cephalalgia26, 113–121 (2006).
   PubMed Web of Science ®Google Scholar
• Freitag F. Diamond S, Diamond M, Urban G, Pepper B. Subcutaneous sumatriptan in patients treated with monoamine oxidase inhibitors and other prophylactic agents. Headache Q.9, 165–171 (1998).
   Web of Science ®Google Scholar
• Fox AW. Subcutaneous sumatriptan pharmacokinetics: delimiting the monoamine oxidase inhibitor effect. Headache50, 249–255 (2010).
   PubMed Web of Science ®Google Scholar
• MacIntyre PD, Bhargava B, Hogg KJ, Gemmill JD, Hillis WS. Effect of subcutaneous sumatriptan, a selective 5HT1 agonist, on the systemic, pulmonary, and coronary circulation. Circulation87, 401–405 (1993).
   PubMed Web of Science ®Google Scholar
• Newman CM, Starkey I, Buller N et al. Effects of sumatriptan and eletriptan on diseased epicardial coronary arteries. Eur. J. Clin. Pharmacol.61, 733–742 (2005).
   PubMed Web of Science ®Google Scholar
• Dodick DW, Martin VT, Smith T, Silberstein S. Cardiovascular tolerability and safety of triptans: a review of clinical data. Headache44(Suppl. 1), S20–S30 (2004).
   PubMedGoogle Scholar
• Evans RW. The FDA alert on serotonin syndrome with combined use of SSRI or SNRI and triptans: an analysis of 29 case reports. MedGenMed9, 48 (2007).
   PubMedGoogle Scholar
• Wenzel RG, Tepper S, Korab WE, Freitag F. Serotonin syndrome risks when combining SSRI/SNRI drugs and triptans: is the FDA’s alert warranted? Ann. Pharmacother.42, 1692–1696 (2008).
   PubMedGoogle Scholar
• Linn L, Boyd B, Iontchev H, King T, Farr SJ. The effects of system parameters on in vivo administration performance of a needle-free injector in humans. Pharm. Res.24, 1501–1507 (2007).
   PubMedGoogle Scholar
• Brandes JL, Cady RK, Freitag FG et al. Needle-free subcutaneous sumatriptan (Sumavel™ DosePro™): bioequivalence and ease of use. Headache49, 1435–1444 (2009).
   PubMed Web of Science ®Google Scholar
• Freidank-Mueschenborn E, Fox AW. Resolution of concentration–response differences in onset of effect between subcutaneous and oral sumatriptan. Headache45(6), 632–637 (2005).
   PubMedGoogle Scholar